ClinicalTrials.gov
ClinicalTrials.gov Menu

Italian Pulmonary Embolism Registry - IPER (IPER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01604538
Recruitment Status : Completed
First Posted : May 23, 2012
Last Update Posted : May 23, 2012
Sponsor:
Information provided by (Responsible Party):
Cecilia Becattini, University Of Perugia

Brief Summary:

RAZIONALE

Pulmonary embolism is a complex disease, with a highly variable clincal presentation. Diagnosis starts with clinical probability assessment mainly based on medical history and rapidly available clinical data. Pulmonary embolism can be managed by emergency department, cardiology, pneumology geriatrics or internal medicine physicians. Thus, initial clinical management can varies based on the attitude of the attending physician.

Diagnosis is a crucial point as it can influence short term mortality.

OBJECTIVE

The registry has 3 main objectives:

  1. educational objective,
  2. improvement in the knowledge of epidemiology, management and outcome of acute pulmonary embolism in Italy
  3. scientific objective

Condition or disease
Acute Pulmonary Embolism

Study Type : Observational
Actual Enrollment : 1700 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Italian Pulmonary Embolism Registry
Study Start Date : March 2006

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort
patients with acute pulmonary embolism




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
consecutive patients with acute pulmonary embolism
Criteria

Inclusion Criteria:

  • consecutive patients with acute pulmonary embolism

Exclusion Criteria:

  • age <18 years

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01604538


Sponsors and Collaborators
University Of Perugia
Investigators
Study Chair: Franco Casazza, MD San Carlo Borromeo hospital, Milan, Italy

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Cecilia Becattini, Dr, University Of Perugia
ClinicalTrials.gov Identifier: NCT01604538     History of Changes
Other Study ID Numbers: protocol_364
First Posted: May 23, 2012    Key Record Dates
Last Update Posted: May 23, 2012
Last Verified: May 2012

Additional relevant MeSH terms:
Embolism
Pulmonary Embolism
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases